Scr, BUN, NGAL, and KIM-1: After the post-3rd dose, there were no statistically significant differences in Scr, BUN, NGAL and KIM-1 levels between the experimental and control groups, indicating that the mice did not develop AKI. Here, LCN2 is linked to acute kidney injury.